25 XP   0   0   10

Ercros
Buy, Hold or Sell?

Let's analyse Ercros together

PenkeI guess you are interested in Ercros. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Ercros. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Ercros

I send you an email if I find something interesting about Ercros.

Quick analysis of Ercros (30 sec.)










What can you expect buying and holding a share of Ercros? (30 sec.)

How much money do you get?

How much money do you get?
‚ā¨0.22
When do you have the money?
1 year
How often do you get paid?
10.3%

What is your share worth?

Current worth
‚ā¨4.00
Expected worth in 1 year
‚ā¨4.30
How sure are you?
64.1%

+ What do you gain per year?

Total Gains per Share
‚ā¨0.50
Return On Investment
14.3%

For what price can you sell your share?

Current Price per Share
‚ā¨3.49
Expected price per share
‚ā¨3.49 - ‚ā¨3.51
How sure are you?
50%

1. Valuation of Ercros (5 min.)




Live pricePrice per Share (EOD)

‚ā¨3.49

2. Growth of Ercros (5 min.)




Is Ercros growing?

Current yearPrevious yearGrowGrow %
How rich?$394.2m$386.4m$6.4m1.6%

How much money is Ercros making?

Current yearPrevious yearGrowGrow %
Making money$6.4m$17.8m-$11.3m-177.2%
Net Profit Margin2.4%7.0%--

How much money comes from the company's main activities?

3. Financial Health of Ercros (5 min.)




4. Comparing to competitors in the Chemicals industry (5 min.)




  Industry Rankings (Chemicals)  


Richest
#158 / 313

Most Revenue
#115 / 313

Most Profit
#124 / 313

Most Efficient
#163 / 313

What can you expect buying and holding a share of Ercros? (5 min.)

Welcome investor! Ercros's management wants to use your money to grow the business. In return you get a share of Ercros.

What can you expect buying and holding a share of Ercros?

First you should know what it really means to hold a share of Ercros. And how you can make/lose money.

Speculation

The Price per Share of Ercros is ‚ā¨3.49. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Ercros.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Ercros, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ‚ā¨4.00. Based on the TTM, the Book Value Change Per Share is ‚ā¨0.07 per quarter. Based on the YOY, the Book Value Change Per Share is ‚ā¨0.08 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ‚ā¨0.05 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Ercros.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ‚ā¨% of Price per Share‚ā¨% of Price per Share‚ā¨% of Price per Share‚ā¨% of Price per Share‚ā¨% of Price per Share
Usd Eps0.041.0%0.123.4%0.175.0%0.113.1%0.092.5%
Usd Book Value Change Per Share-0.12-3.5%0.082.3%0.082.4%0.082.3%0.071.9%
Usd Dividend Per Share0.000.0%0.051.5%0.051.3%0.020.5%0.010.3%
Usd Total Gains Per Share-0.12-3.5%0.133.9%0.133.7%0.102.8%0.082.2%
Usd Price Per Share3.78-3.35-3.79-3.04-2.61-
Price to Earnings Ratio26.30-12.06-7.96-24.96-18.29-
Price-to-Total Gains Ratio-31.21--2.28--202.09-41.58-373.88-
Price to Book Ratio0.88-0.78-0.95-0.86-0.89-
Price-to-Total Gains Ratio-31.21--2.28--202.09-41.58-373.88-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.757683
Number of shares266
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.050.02
Usd Book Value Change Per Share0.080.08
Usd Total Gains Per Share0.130.10
Gains per Quarter (266 shares)35.7626.14
Gains per Year (266 shares)143.04104.55
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
15786133198595
211517227639170200
317225741958256305
422934356277341410
528642970597426515
6344515848116511620
7401600991135597725
84586861134155682830
95167721277174767935
1057385814201938521040

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.00.00.0100.0%11.00.00.0100.0%19.00.00.0100.0%38.01.00.097.4%48.04.08.080.0%
Book Value Change Per Share2.01.00.066.7%8.03.00.072.7%14.04.01.073.7%25.09.05.064.1%33.020.07.055.0%
Dividend per Share1.00.02.033.3%3.00.08.027.3%3.00.016.015.8%4.00.035.010.3%11.00.049.018.3%
Total Gains per Share2.01.00.066.7%8.03.00.072.7%14.04.01.073.7%25.09.05.064.1%34.020.06.056.7%

Fundamentals of Ercros

About Ercros

Ercros, S.A. manufactures and sells basic chemicals, intermediate chemicals, and pharmaceuticals in Spain. It operates through three segments: Chlorine Derivatives, Intermediate Chemicals, and Pharmacy. The Chlorine Derivatives segment produces ammonia, bioplastics, caustic potash and soda, chlorine, chloroisocyanurates, dicalcium phosphate, dichloroethane, hydrochloric acid, hydrogen peroxide, potassium carbonate, PVC compounds, sodium chlorate and chlorite, sodium hypochlorite, and vinyl chloride monomers and polychloride. This segment's products are used as intermediates in other industrial processes to purify and treat drinking and waste water; treat and maintain swimming pool water; bleach fabrics and paper; produce solvents, detergents, and strippers; manufacture printing inks and coloring; to produce compound feed and in cooling equipment. The Intermediate Chemicals segment provides formaldehyde, glues and resins, molding compunds, paraformaldehyde, pentaerythritol and dipentaerythritol, and sodium formate for manufacturing of particle, and decorative laminates and plywoods, as well as resins, paints, and varnishes in the furniture and decoration industry; sockets and switches in the electrical components sector; and tableware, and health and packaging items in the textile tanning industry. The Pharmacy division engages in the production of raw materials and pharmaceutical intermediate products from antibiotic, cholesterol-lowering, anti-ulcer, and anti-fungal agents. This segment's products include amlodipine besylate, azithromycin, clarithromycin, erythromycins, famotidine, fosfomycin calcium and sodium, fosfomycin trometamol, and fusidic acid. The company is also involved in exporting activities. Ercros, S.A. was founded in 1817 and is headquartered in Barcelona, Spain.

Fundamental data was last updated by Penke on 2024-06-06 13:36:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Ercros.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit¬†Ercros earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare¬†Ercros to the¬†Chemicals industry mean.
  • A Net Profit Margin of 1.7%¬†means that¬†€0.02 for each €1¬†in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Ercros:

  • The MRQ is 1.7%. The company is making a profit. +1
  • The TTM is 2.4%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ1.7%TTM2.4%-0.7%
TTM2.4%YOY7.0%-4.6%
TTM2.4%5Y3.9%-1.5%
5Y3.9%10Y4.1%-0.2%
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7%2.6%-0.9%
TTM2.4%2.7%-0.3%
YOY7.0%5.0%+2.0%
5Y3.9%5.0%-1.1%
10Y4.1%5.3%-1.2%
1.1.2. Return on Assets

Shows how efficient Ercros is using its assets to generate profit.

  • Above 5% is considered healthy¬†but always compare¬†Ercros to the¬†Chemicals industry mean.
  • 0.5% Return on Assets means that¬†Ercros generated¬†€0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Ercros:

  • The MRQ is 0.5%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.9%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.5%TTM0.9%-0.4%
TTM0.9%YOY2.3%-1.4%
TTM0.9%5Y1.4%-0.5%
5Y1.4%10Y1.3%+0.1%
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5%0.5%0.0%
TTM0.9%0.5%+0.4%
YOY2.3%1.1%+1.2%
5Y1.4%1.1%+0.3%
10Y1.3%1.2%+0.1%
1.1.3. Return on Equity

Shows how efficient Ercros is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare¬†Ercros to the¬†Chemicals industry mean.
  • 0.8% Return on Equity means Ercros generated €0.01¬†for each¬†€1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Ercros:

  • The MRQ is 0.8%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 1.7%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.8%TTM1.7%-0.8%
TTM1.7%YOY4.6%-3.0%
TTM1.7%5Y2.9%-1.2%
5Y2.9%10Y3.0%-0.1%
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8%1.1%-0.3%
TTM1.7%1.1%+0.6%
YOY4.6%2.0%+2.6%
5Y2.9%1.9%+1.0%
10Y3.0%2.2%+0.8%

1.2. Operating Efficiency of Ercros.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Ercros is operating .

  • Measures how much profit Ercros makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare¬†Ercros to the¬†Chemicals industry mean.
  • An Operating Margin of 3.6%¬†means the company generated €0.04 ¬†for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Ercros:

  • The MRQ is 3.6%. The company is operating less efficient.
  • The TTM is -1.8%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ3.6%TTM-1.8%+5.5%
TTM-1.8%YOY9.7%-11.6%
TTM-1.8%5Y4.0%-5.8%
5Y4.0%10Y4.0%+0.0%
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ3.6%6.0%-2.4%
TTM-1.8%1.5%-3.3%
YOY9.7%5.9%+3.8%
5Y4.0%6.8%-2.8%
10Y4.0%5.8%-1.8%
1.2.2. Operating Ratio

Measures how efficient Ercros is keeping operating costs low.

  • Below 1 is considered healthy (always compare to¬†Chemicals industry mean).
  • An Operation Ratio of 0.96 means that the operating costs are €0.96 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Ercros:

  • The MRQ is 0.964. The company is less efficient in keeping operating costs low.
  • The TTM is 1.017. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ0.964TTM1.017-0.053
TTM1.017YOY0.902+0.114
TTM1.0175Y0.850+0.166
5Y0.85010Y0.839+0.012
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9641.727-0.763
TTM1.0171.719-0.702
YOY0.9021.652-0.750
5Y0.8501.647-0.797
10Y0.8391.351-0.512

1.3. Liquidity of Ercros.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Ercros is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to¬†Chemicals industry mean).
  • A Current Ratio of 1.74¬†means the company has €1.74 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Ercros:

  • The MRQ is 1.742. The company is able to pay all its short-term debts. +1
  • The TTM is 1.473. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.742TTM1.473+0.268
TTM1.473YOY1.378+0.096
TTM1.4735Y1.324+0.149
5Y1.32410Y1.139+0.185
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7421.595+0.147
TTM1.4731.599-0.126
YOY1.3781.661-0.283
5Y1.3241.793-0.469
10Y1.1391.380-0.241
1.3.2. Quick Ratio

Measures if Ercros is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but¬†always compare¬†Ercros to the¬†Chemicals industry mean.
  • A Quick Ratio of -1.06¬†means the company can pay off €-1.06 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Ercros:

  • The MRQ is -1.061. The company is unable to pay all its short-term debts with the most liquid assets. -2
  • The TTM is 0.073. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ-1.061TTM0.073-1.134
TTM0.073YOY0.307-0.234
TTM0.0735Y0.331-0.258
5Y0.33110Y0.337-0.006
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.0610.512-1.573
TTM0.0730.558-0.485
YOY0.3070.726-0.419
5Y0.3310.746-0.415
10Y0.3370.751-0.414

1.4. Solvency of Ercros.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Ercros assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare¬†Ercros to Chemicals industry mean.
  • A Debt to Asset Ratio of 0.40¬†means that Ercros assets are¬†financed with 40.4% credit (debt) and the remaining percentage (100% - 40.4%)¬†is financed by its owners/shareholders.¬†

Let's take a look of the Debt to Asset Ratio trends of Ercros:

  • The MRQ is 0.404. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.451. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.404TTM0.451-0.047
TTM0.451YOY0.483-0.031
TTM0.4515Y0.498-0.046
5Y0.49810Y0.531-0.033
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4040.444-0.040
TTM0.4510.431+0.020
YOY0.4830.425+0.058
5Y0.4980.414+0.084
10Y0.5310.415+0.116
1.4.2. Debt to Equity Ratio

Measures if Ercros is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but¬†always compare¬†Ercros to the¬†Chemicals industry mean.
  • A Debt to Equity ratio of 67.9% means that company has €0.68 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Ercros:

  • The MRQ is 0.679. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.843. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.679TTM0.843-0.164
TTM0.843YOY0.946-0.103
TTM0.8435Y1.011-0.168
5Y1.01110Y1.243-0.232
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6790.860-0.181
TTM0.8430.810+0.033
YOY0.9460.762+0.184
5Y1.0110.752+0.259
10Y1.2430.815+0.428

2. Market Valuation of Ercros

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures¬†how much money you pay¬†for each share for¬†every €1 in earnings Ercros generates.

  • Above 15 is considered overpriced but¬†always compare¬†Ercros to the¬†Chemicals industry mean.
  • A PE ratio of 26.30 means the investor is paying €26.30¬†for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Ercros:

  • The EOD is 26.148. Based on the earnings, the company is overpriced. -1
  • The MRQ is 26.298. Based on the earnings, the company is overpriced. -1
  • The TTM is 12.057. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD26.148MRQ26.298-0.150
MRQ26.298TTM12.057+14.241
TTM12.057YOY7.964+4.092
TTM12.0575Y24.964-12.907
5Y24.96410Y18.294+6.670
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD26.14813.253+12.895
MRQ26.29812.766+13.532
TTM12.05712.836-0.779
YOY7.96411.783-3.819
5Y24.96415.075+9.889
10Y18.29423.525-5.231
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Ercros:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-9.246+9.246
TTM-9.246YOY5.438-14.685
TTM-9.2465Y-0.315-8.931
5Y-0.31510Y-0.154-0.162
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ--3.687+3.687
TTM-9.2460.145-9.391
YOY5.4381.382+4.056
5Y-0.3151.620-1.935
10Y-0.1542.004-2.158
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Ercros is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy¬†(always compare to Chemicals industry mean).
  • A PB ratio of 0.88 means the investor is paying €0.88¬†for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Ercros:

  • The EOD is 0.871. Based on the equity, the company is cheap. +2
  • The MRQ is 0.876. Based on the equity, the company is cheap. +2
  • The TTM is 0.782. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.871MRQ0.876-0.005
MRQ0.876TTM0.782+0.094
TTM0.782YOY0.949-0.167
TTM0.7825Y0.859-0.077
5Y0.85910Y0.893-0.034
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD0.8711.285-0.414
MRQ0.8761.351-0.475
TTM0.7821.425-0.643
YOY0.9491.749-0.800
5Y0.8591.750-0.891
10Y0.8932.170-1.277
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Ercros compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.1120.075-250%0.078-244%0.074-251%0.061-283%
Book Value Per Share--4.0053.991+0%3.706+8%3.272+22%2.684+49%
Current Ratio--1.7421.473+18%1.378+26%1.324+32%1.139+53%
Debt To Asset Ratio--0.4040.451-10%0.483-16%0.498-19%0.531-24%
Debt To Equity Ratio--0.6790.843-19%0.946-28%1.011-33%1.243-45%
Dividend Per Share---0.050-100%0.043-100%0.017-100%0.009-100%
Eps--0.0330.112-70%0.162-79%0.101-67%0.082-60%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Market Cap319112338.000-1%320941062.000284671369.333+13%340750353.430-6%276295150.903+16%248319029.996+29%
Net Profit Margin--0.0170.024-30%0.070-76%0.039-57%0.041-59%
Operating Margin--0.036-0.018+150%0.097-63%0.040-10%0.040-9%
Operating Ratio--0.9641.017-5%0.902+7%0.850+13%0.839+15%
Pb Ratio0.871-1%0.8760.782+12%0.949-8%0.859+2%0.893-2%
Pe Ratio26.148-1%26.29812.057+118%7.964+230%24.964+5%18.294+44%
Price Per Share3.490-1%3.5103.113+13%3.5190%2.822+24%2.420+45%
Price To Free Cash Flow Ratio----9.2460%5.438-100%-0.3150%-0.1540%
Price To Total Gains Ratio-31.033+1%-31.211-2.278-93%-202.092+548%41.576-175%373.880-108%
Quick Ratio---1.0610.073-1555%0.307-445%0.331-420%0.337-415%
Return On Assets--0.0050.009-44%0.023-78%0.014-65%0.013-63%
Return On Equity--0.0080.017-50%0.046-82%0.029-71%0.030-72%
Total Gains Per Share---0.1120.125-190%0.121-193%0.091-223%0.071-259%
Usd Book Value--394250932.200392880652.000+0%386401250.850+2%344730042.426+14%297617990.646+32%
Usd Book Value Change Per Share---0.1210.081-250%0.084-244%0.080-251%0.066-283%
Usd Book Value Per Share--4.3124.297+0%3.990+8%3.523+22%2.890+49%
Usd Dividend Per Share---0.054-100%0.046-100%0.018-100%0.010-100%
Usd Eps--0.0360.120-70%0.174-79%0.109-67%0.089-60%
Usd Free Cash Flow---6210764.500-100%11766446.506-100%3457793.659-100%1684566.142-100%
Usd Market Cap343588254.325-1%345557241.455306505663.361+13%366885905.538-6%297486988.977+16%267365099.596+29%
Usd Price Per Share3.758-1%3.7793.352+13%3.7890%3.039+24%2.606+45%
Usd Profit--3285011.7006427899.000-49%17815347.375-82%10099275.995-67%8840673.269-63%
Usd Revenue--196612956.900247565989.900-21%255762548.100-23%192686118.663+2%182372163.800+8%
Usd Total Gains Per Share---0.1210.134-190%0.130-193%0.098-223%0.076-259%
 EOD+4 -3MRQTTM+11 -19YOY+10 -215Y+10 -2010Y+11 -19

3.2. Fundamental Score

Let's check the fundamental score of Ercros based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1526.148
Price to Book Ratio (EOD)Between0-10.871
Net Profit Margin (MRQ)Greater than00.017
Operating Margin (MRQ)Greater than00.036
Quick Ratio (MRQ)Greater than1-1.061
Current Ratio (MRQ)Greater than11.742
Debt to Asset Ratio (MRQ)Less than10.404
Debt to Equity Ratio (MRQ)Less than10.679
Return on Equity (MRQ)Greater than0.150.008
Return on Assets (MRQ)Greater than0.050.005
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Ercros based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.971
Ma 20Greater thanMa 503.499
Ma 50Greater thanMa 1003.520
Ma 100Greater thanMa 2003.144
OpenGreater thanClose3.495
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets614,639
Total Liabilities248,473
Total Stockholder Equity366,166
 As reported
Total Liabilities 248,473
Total Stockholder Equity+ 366,166
Total Assets = 614,639

Assets

Total Assets614,639
Total Current Assets185,830
Long-term Assets428,809
Total Current Assets
Cash And Cash Equivalents -113,165
Total Current Assets  (as reported)185,830
Total Current Assets  (calculated)-113,165
+/- 298,995
Long-term Assets
Long-term Assets  (as reported)428,809
Long-term Assets  (calculated)0
+/- 428,809

Liabilities & Shareholders' Equity

Total Current Liabilities106,699
Long-term Liabilities141,774
Total Stockholder Equity366,166
Total Current Liabilities
Total Current Liabilities  (as reported)106,699
Total Current Liabilities  (calculated)0
+/- 106,699
Long-term Liabilities
Long-term Liabilities  (as reported)141,774
Long-term Liabilities  (calculated)0
+/- 141,774
Total Stockholder Equity
Total Stockholder Equity (as reported)366,166
Total Stockholder Equity (calculated)0
+/- 366,166
Other
Cash and Short Term Investments -113,165
Common Stock Shares Outstanding 91,436
Liabilities and Stockholders Equity 614,639
Net Debt 226,330
Net Working Capital 79,131
Short Long Term Debt Total 113,165



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2024-03-312023-12-312023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-06-302010-03-312009-12-312009-06-302009-03-312008-12-312008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-06-302003-12-312003-06-302002-12-312002-06-302001-06-302000-12-312000-06-30
> Total Assets 
57,634,000
56,930,000
57,881,000
339,753
340,140
348,431
353,550
368,561
361,870
369,090
650,315
0
761,810
0
1,000,348
1,005,780
0
942,698
812,060
949,030
896,930
942,410
707,030
673,900
673,900
640,100
0
650,405
626,690
665,000
666,628
551,270
605,560
546,110
632,110
547,020
605,180
535,550
593,540
505,620
564,290
491,930
547,650
475,430
520,720
461,050
538,440
498,750
511,680
447,410
538,580
0
560,180
0
560,750
0
599,173
530,398
599,418
0
606,571
559,631
652,767
579,348
656,415
0
596,089
524,977
590,219
534,041
635,436
558,117
709,956
664,829
751,171
660,901
746,551
633,698
705,692
683,315
614,639
614,639683,315705,692633,698746,551660,901751,171664,829709,956558,117635,436534,041590,219524,977596,0890656,415579,348652,767559,631606,5710599,418530,398599,1730560,7500560,1800538,580447,410511,680498,750538,440461,050520,720475,430547,650491,930564,290505,620593,540535,550605,180547,020632,110546,110605,560551,270666,628665,000626,690650,4050640,100673,900673,900707,030942,410896,930949,030812,060942,69801,005,7801,000,3480761,8100650,315369,090361,870368,561353,550348,431340,140339,75357,881,00056,930,00057,634,000
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
279,140
0
294,227
275,540
0
320,724
0
270,790
0
296,510
250,520
273,970
241,290
268,710
217,920
254,860
225,400
244,530
207,140
228,150
198,110
250,070
188,660
226,960
191,250
250,940
0
254,560
0
245,300
0
248,727
208,142
239,208
0
239,490
211,971
255,490
211,270
251,380
237,213
188,894
160,184
191,017
179,398
239,999
199,672
301,780
289,712
314,097
274,531
300,179
240,239
256,706
209,449
185,830
185,830209,449256,706240,239300,179274,531314,097289,712301,780199,672239,999179,398191,017160,184188,894237,213251,380211,270255,490211,971239,4900239,208208,142248,7270245,3000254,5600250,940191,250226,960188,660250,070198,110228,150207,140244,530225,400254,860217,920268,710241,290273,970250,520296,5100270,7900320,7240275,540294,2270279,1400000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
35,560
0
38,333
34,100
0
57,979
0
7,560
0
8,850
0
11,590
0
15,170
0
16,200
0
17,440
0
19,890
0
22,660
0
21,620
0
41,340
0
48,260
0
19,470
0
22,743
0
20,203
0
15,845
0
38,288
0
55,466
0
25,985
0
38,249
0
48,766
0
50,305
0
34,811
0
55,480
0
31,200
39,145
-113,165
-113,16539,14531,200055,480034,811050,305048,766038,249025,985055,466038,288015,845020,203022,743019,470048,260041,340021,620022,660019,890017,440016,200015,170011,59008,85007,560057,979034,10038,333035,5600000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
34,940
0
0
0
0
0
9,810
0
0
0
10,080
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-23,923
0
-30,122
0
-29,595
0
0
00-29,5950-30,1220-23,9230000000000000000000000000000010,0800009,8100000034,9400000000000000000000000000000000000
       Net Receivables 
11,382,000
11,971,000
13,436,000
70,881
69,330
70,463
70,990
93,521
86,040
0
181,018
0
149,650
0
224,647
212,230
0
235,305
0
215,910
0
230,320
215,340
186,140
186,140
151,260
0
159,390
156,800
0
180,118
0
155,800
0
177,550
0
152,990
0
161,510
0
164,940
0
143,450
0
135,290
0
146,780
0
140,380
0
150,200
0
124,870
0
146,510
0
133,650
0
121,745
0
115,767
0
129,734
0
110,229
0
84,537
0
56,070
94,526
94,526
0
124,858
0
145,920
0
107,180
0
116,476
64,956
0
064,956116,4760107,1800145,9200124,858094,52694,52656,070084,5370110,2290129,7340115,7670121,7450133,6500146,5100124,8700150,2000140,3800146,7800135,2900143,4500164,9400161,5100152,9900177,5500155,8000180,1180156,800159,3900151,260186,140186,140215,340230,3200215,9100235,3050212,230224,6470149,6500181,018086,04093,52170,99070,46369,33070,88113,436,00011,971,00011,382,000
       Other Current Assets 
2,205,000
595,000
2,074,000
2,138
2,260
2,413
1,910
1,824
1,370
133,270
12,144
0
25,950
0
72,991
61,740
0
60,789
299,450
69,920
408,080
27,810
5,090
1,620
1,620
18,340
0
30,760
17,050
314,120
16,993
245,690
33,970
248,090
177,550
250,520
33,510
241,290
33,720
217,920
3,400
225,400
32,620
207,140
7,360
198,110
30,150
188,660
7,110
191,250
4,010
0
9,420
0
14,170
0
12,595
208,142
13,621
0
10,203
211,971
4,215
211,270
3,441
189,902
3,035
160,184
4,784
179,398
8,690
199,672
3,921
289,712
4,978
274,531
2,746
240,239
2,061
1,070
0
01,0702,061240,2392,746274,5314,978289,7123,921199,6728,690179,3984,784160,1843,035189,9023,441211,2704,215211,97110,203013,621208,14212,595014,17009,42004,010191,2507,110188,66030,150198,1107,360207,14032,620225,4003,400217,92033,720241,29033,510250,520177,550248,09033,970245,69016,993314,12017,05030,760018,3401,6201,6205,09027,810408,08069,920299,45060,789061,74072,991025,950012,144133,2701,3701,8241,9102,4132,2602,1382,074,000595,0002,205,000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
360,960
0
356,178
351,150
0
345,904
0
334,770
0
335,600
296,500
331,210
294,260
324,830
287,700
309,430
266,530
303,120
268,290
292,570
262,940
288,370
253,970
284,720
256,160
287,640
0
305,620
0
315,450
0
350,446
322,256
360,210
0
367,081
0
397,277
368,078
405,035
0
407,195
364,793
399,202
354,643
395,437
358,445
408,176
375,117
437,074
386,370
446,372
393,459
448,986
473,866
428,809
428,809473,866448,986393,459446,372386,370437,074375,117408,176358,445395,437354,643399,202364,793407,1950405,035368,078397,2770367,0810360,210322,256350,4460315,4500305,6200287,640256,160284,720253,970288,370262,940292,570268,290303,120266,530309,430287,700324,830294,260331,210296,500335,6000334,7700345,9040351,150356,1780360,9600000000000000000000000000
       Property Plant Equipment 
33,349,000
33,372,000
32,695,000
201,943
202,880
218,706
215,360
216,958
208,740
215,430
364,161
0
437,190
0
522,210
526,560
0
494,684
0
469,320
0
474,170
270,770
323,170
323,170
310,610
0
304,242
300,740
0
295,324
0
279,710
0
279,290
0
277,140
0
270,390
0
264,370
0
255,420
0
245,690
0
239,900
0
235,290
0
235,630
0
249,230
0
260,470
0
269,388
0
275,729
0
281,689
17,613
303,450
0
309,870
0
313,448
0
320,194
323,370
323,370
0
330,634
0
351,284
0
353,760
0
355,140
354,300
0
0354,300355,1400353,7600351,2840330,6340323,370323,370320,1940313,4480309,8700303,45017,613281,6890275,7290269,3880260,4700249,2300235,6300235,2900239,9000245,6900255,4200264,3700270,3900277,1400279,2900279,7100295,3240300,740304,2420310,610323,170323,170270,770474,1700469,3200494,6840526,560522,2100437,1900364,161215,430208,740216,958215,360218,706202,880201,94332,695,00033,372,00033,349,000
       Goodwill 
0
7,000
0
0
0
0
0
0
0
0
0
0
0
0
0
50
0
0
0
0
0
0
0
650
650
40
0
0
40
0
0
0
40
0
0
0
40
0
0
0
40
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000040000400004000040004065065000000005000000000000007,0000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,950
0
6,470
0
6,503
0
6,893
0
6,840
0
7,056
0
6,654
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000006,65407,05606,84006,89306,50306,47006,9500000000000000000000000000000000000000000000000000000
       Intangible Assets 
1,729,000
1,569,000
2,015,000
12,722
11,320
2,142
10,090
2,682
8,620
1,820
1,859
0
3,980
0
9,667
8,700
0
7,547
0
2,930
0
11,420
9,000
11,150
11,150
8,200
0
10,059
8,520
0
7,578
0
5,640
0
6,450
0
4,490
0
5,260
0
4,780
0
4,290
0
5,550
0
6,600
0
6,540
0
6,290
0
5,860
0
4,720
0
4,097
0
4,711
0
4,226
0
7,070
0
6,795
0
0
0
7,162
0
0
0
11,598
0
18,604
0
19,034
0
20,202
19,964
0
019,96420,202019,034018,604011,5980007,1620006,79507,07004,22604,71104,09704,72005,86006,29006,54006,60005,55004,29004,78005,26004,49006,45005,64007,57808,52010,05908,20011,15011,1509,00011,42002,93007,54708,7009,66703,98001,8591,8208,6202,68210,0902,14211,32012,7222,015,0001,569,0001,729,000
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
38,810
0
38,384
38,440
0
39,602
0
49,420
0
75,430
296,500
46,200
294,260
45,810
287,700
40,310
266,530
40,150
268,290
43,270
262,940
40,330
253,970
40,390
256,160
43,410
0
43,540
0
41,880
0
51,030
322,256
54,501
0
49,466
0
56,361
368,078
48,107
0
47,581
364,793
32,936
354,643
35,778
358,445
30,286
375,117
3,392
386,370
446
0
838
443
0
04438380446386,3703,392375,11730,286358,44535,778354,64332,936364,79347,581048,107368,07856,361049,466054,501322,25651,030041,880043,540043,410256,16040,390253,97040,330262,94043,270268,29040,150266,53040,310287,70045,810294,26046,200296,50075,430049,420039,602038,44038,384038,8100000000000000000000000000
> Total Liabilities 
36,174,000
35,262,000
35,087,000
200,709
194,550
203,604
225,750
254,214
266,810
278,330
541,471
0
507,940
0
626,860
645,810
0
495,031
346,440
485,890
437,470
484,610
449,830
436,180
436,180
434,720
0
456,155
434,460
469,060
467,384
354,790
418,450
364,720
451,180
368,440
431,310
255,350
422,470
212,880
392,080
196,000
371,630
194,820
352,530
185,690
364,100
182,780
335,800
174,490
343,510
0
340,350
0
330,770
0
351,681
277,831
338,169
0
333,902
286,934
381,242
301,014
364,332
0
313,762
242,447
306,004
242,311
334,811
253,890
378,343
323,020
395,412
305,502
385,841
270,064
353,627
306,866
248,473
248,473306,866353,627270,064385,841305,502395,412323,020378,343253,890334,811242,311306,004242,447313,7620364,332301,014381,242286,934333,9020338,169277,831351,6810330,7700340,3500343,510174,490335,800182,780364,100185,690352,530194,820371,630196,000392,080212,880422,470255,350431,310368,440451,180364,720418,450354,790467,384469,060434,460456,1550434,720436,180436,180449,830484,610437,470485,890346,440495,0310645,810626,8600507,9400541,471278,330266,810254,214225,750203,604194,550200,70935,087,00035,262,00036,174,000
   > Total Current Liabilities 
15,468,000
17,996,000
16,697,000
90,710
94,470
87,842
100,060
124,698
123,420
130,020
265,191
0
217,430
0
344,623
413,590
0
307,114
164,560
292,220
218,310
296,570
275,930
253,430
253,430
204,990
0
312,067
300,440
334,390
326,661
192,750
274,370
260,980
301,180
267,390
302,500
204,000
280,990
155,110
268,170
147,490
256,400
151,130
252,250
144,730
262,440
142,080
231,300
135,850
239,070
0
216,050
0
220,660
0
244,167
121,616
227,471
0
233,900
114,067
252,847
122,867
243,395
205,755
163,899
116,548
163,815
126,979
191,978
164,158
232,286
200,385
247,724
200,672
222,558
157,396
183,196
163,998
106,699
106,699163,998183,196157,396222,558200,672247,724200,385232,286164,158191,978126,979163,815116,548163,899205,755243,395122,867252,847114,067233,9000227,471121,616244,1670220,6600216,0500239,070135,850231,300142,080262,440144,730252,250151,130256,400147,490268,170155,110280,990204,000302,500267,390301,180260,980274,370192,750326,661334,390300,440312,0670204,990253,430253,430275,930296,570218,310292,220164,560307,1140413,590344,6230217,4300265,191130,020123,420124,698100,06087,84294,47090,71016,697,00017,996,00015,468,000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
42,450
0
116,754
110,130
0
102,880
0
81,060
0
98,490
57,150
100,660
0
121,480
0
113,560
0
117,360
0
106,350
0
113,750
0
98,370
0
103,380
0
89,340
148,150
76,140
125,370
79,620
98,887
67,202
0
83,837
0
112,672
0
109,791
0
42,647
0
34,127
0
36,658
0
24,601
0
31,146
0
30,945
0
39,059
31,732
0
031,73239,059030,945031,146024,601036,658034,127042,6470109,7910112,672083,837067,20298,88779,620125,37076,140148,15089,3400103,380098,3700113,7500106,3500117,3600113,5600121,4800100,66057,15098,490081,0600102,8800110,130116,754042,4500000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
148,150
148,150
125,370
125,370
11,823
98,887
10,120
0
9,858
0
105,965
0
103,173
0
36,593
0
28,712
0
31,758
0
20,983
0
25,521
0
25,952
0
34,119
27,347
0
027,34734,119025,952025,521020,983031,758028,712036,5930103,1730105,96509,858010,12098,88711,823125,370125,370148,150148,1500000000000000000000000000000000000000000000000000000
       Accounts payable 
5,186,000
5,697,000
5,961,000
38,627
34,970
33,836
31,890
35,702
37,730
0
121,518
0
106,240
0
152,236
160,880
0
167,260
0
147,450
0
155,490
130,820
118,250
118,250
130,680
0
146,120
139,450
0
174,280
0
153,260
200,900
171,490
210,240
169,860
204,000
137,070
155,110
137,290
147,490
121,970
151,130
130,070
144,730
132,750
142,080
114,010
135,850
116,730
0
106,850
0
114,850
0
119,460
121,616
114,046
0
107,655
0
113,644
0
101,226
121,825
93,202
0
102,447
126,979
124,701
164,158
169,905
0
165,342
0
139,027
0
104,515
90,909
0
090,909104,5150139,0270165,3420169,905164,158124,701126,979102,447093,202121,825101,2260113,6440107,6550114,046121,616119,4600114,8500106,8500116,730135,850114,010142,080132,750144,730130,070151,130121,970147,490137,290155,110137,070204,000169,860210,240171,490200,900153,2600174,2800139,450146,1200130,680118,250118,250130,820155,4900147,4500167,2600160,880152,2360106,2400121,518037,73035,70231,89033,83634,97038,6275,961,0005,697,0005,186,000
       Other Current Liabilities 
4,492,000
4,458,000
4,565,000
22,640
20,680
19,273
24,630
49,316
23,780
130,020
27,372
0
31,560
0
61,278
78,030
0
70,694
164,560
59,450
218,310
60,750
62,200
83,760
83,760
162,540
0
40,452
190,310
334,390
46,944
192,750
37,520
0
29,920
210,240
25,120
204,000
13,310
155,110
7,170
147,490
8,700
151,130
5,330
144,730
5,900
142,080
7,660
135,850
14,410
0
5,320
0
17,850
0
4,689
121,616
14,628
0
4,104
114,067
5,803
122,867
4,179
0
4,740
116,548
4,197
126,979
18,524
164,158
4,369
200,385
49,910
200,672
51,130
157,396
6,839
40,316
0
040,3166,839157,39651,130200,67249,910200,3854,369164,15818,524126,9794,197116,5484,74004,179122,8675,803114,0674,104014,628121,6164,689017,85005,320014,410135,8507,660142,0805,900144,7305,330151,1308,700147,4907,170155,11013,310204,00025,120210,24029,920037,520192,75046,944334,390190,31040,4520162,54083,76083,76062,20060,750218,31059,450164,56070,694078,03061,278031,560027,372130,02023,78049,31624,63019,27320,68022,6404,565,0004,458,0004,492,000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
229,730
0
144,088
134,020
0
140,723
0
144,080
0
150,000
101,050
128,810
51,350
141,480
57,770
123,910
48,510
115,230
43,690
100,280
40,960
101,660
40,700
104,500
38,640
104,440
0
124,300
0
110,110
0
107,514
156,215
110,698
0
100,002
0
128,395
178,147
120,937
0
149,863
125,899
142,189
115,332
142,833
89,732
146,057
122,635
147,688
104,830
163,283
112,668
170,431
142,868
141,774
141,774142,868170,431112,668163,283104,830147,688122,635146,05789,732142,833115,332142,189125,899149,8630120,937178,147128,3950100,0020110,698156,215107,5140110,1100124,3000104,44038,640104,50040,700101,66040,960100,28043,690115,23048,510123,91057,770141,48051,350128,810101,050150,0000144,0800140,7230134,020144,0880229,7300000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
92,068
0
104,482
0
103,236
0
0
00103,2360104,482092,06800000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
46,240
41,373
53,760
53,958
87,420
148,310
100,085
0
123,730
0
105,883
72,250
0
98,527
72,020
78,000
76,550
74,610
63,800
40,570
40,570
119,230
0
105,770
58,750
134,670
103,000
49,620
41,390
35,190
42,980
35,280
36,060
38,490
36,560
36,740
32,670
36,940
32,880
31,760
30,750
37,290
31,820
37,210
34,870
41,620
39,450
0
39,500
0
34,930
0
35,493
57,328
59,851
0
51,609
23,829
56,373
38,987
48,193
20,734
50,074
18,769
44,906
17,938
46,981
17,023
50,656
20,089
55,620
17,399
58,801
0
0
0
0
000058,80117,39955,62020,08950,65617,02346,98117,93844,90618,76950,07420,73448,19338,98756,37323,82951,609059,85157,32835,493034,930039,500039,45041,62034,87037,21031,82037,29030,75031,76032,88036,94032,67036,74036,56038,49036,06035,28042,98035,19041,39049,620103,000134,67058,750105,7700119,23040,57040,57063,80074,61076,55078,00072,02098,527072,250105,8830123,7300100,085148,31087,42053,95853,76041,37346,2400000
> Total Stockholder Equity
21,223,000
21,463,000
22,609,000
137,875
144,900
144,138
127,080
113,771
94,610
90,340
106,612
108,844
251,330
253,870
371,511
358,000
359,970
446,210
465,620
462,230
459,460
457,570
255,920
237,210
237,210
205,120
205,380
193,893
191,770
195,470
198,702
196,480
186,740
181,390
180,741
178,580
173,870
168,000
171,070
171,390
172,210
170,370
176,020
177,120
168,190
169,310
174,340
174,660
175,880
183,800
195,070
0
219,830
219,830
229,980
229,980
247,492
252,567
261,249
261,249
272,669
272,697
271,525
278,334
292,083
0
282,327
282,530
284,215
291,730
300,625
304,227
331,613
341,809
355,759
355,399
360,710
363,634
352,065
363,115
366,166
366,166363,115352,065363,634360,710355,399355,759341,809331,613304,227300,625291,730284,215282,530282,3270292,083278,334271,525272,697272,669261,249261,249252,567247,492229,980229,980219,830219,8300195,070183,800175,880174,660174,340169,310168,190177,120176,020170,370172,210171,390171,070168,000173,870178,580180,741181,390186,740196,480198,702195,470191,770193,893205,380205,120237,210237,210255,920457,570459,460462,230465,620446,210359,970358,000371,511253,870251,330108,844106,61290,34094,610113,771127,080144,138144,900137,87522,609,00021,463,00021,223,000
   Common Stock
14,011,000
14,011,000
14,011,000
84,206
84,210
84,206
84,210
84,206
84,210
84,210
84,206
0
203,640
0
258,745
258,750
0
362,243
465,620
362,240
459,460
362,240
362,240
161,000
161,000
161,000
0
30,187
30,190
195,470
30,187
196,480
30,190
181,390
30,187
178,580
30,450
168,000
31,100
171,390
32,110
170,370
33,310
177,120
33,680
169,310
34,220
174,660
34,220
183,800
34,220
0
34,220
0
34,220
0
33,294
252,567
33,294
0
32,363
272,697
32,363
278,334
31,475
285,910
31,475
282,530
30,292
291,730
30,292
304,227
30,292
341,809
30,292
355,399
28,980
0
28,980
27,431
0
027,43128,980028,980355,39930,292341,80930,292304,22730,292291,73030,292282,53031,475285,91031,475278,33432,363272,69732,363033,294252,56733,294034,220034,220034,220183,80034,220174,66034,220169,31033,680177,12033,310170,37032,110171,39031,100168,00030,450178,58030,187181,39030,190196,48030,187195,47030,19030,1870161,000161,000161,000362,240362,240459,460362,240465,620362,2430258,750258,7450203,640084,20684,21084,21084,20684,21084,20684,21084,20614,011,00014,011,00014,011,000
   Retained Earnings 
52,000
294,000
1,146,000
0
7,350
0
0
0
0
0
21,226
0
41,790
0
10,863
22,230
0
0
0
0
0
0
0
3,540
3,540
0
0
-9,546
177,280
0
6,143
0
172,330
0
-5,703
0
159,930
0
-3,700
0
156,490
0
2,360
0
135,070
0
5,550
0
141,570
0
19,640
0
185,520
0
39,410
0
44,492
0
236,267
0
44,876
0
10,493
0
31,043
0
4,374
0
6,257
20,265
20,265
0
43,297
0
46,293
0
62,989
0
16,539
27,585
0
027,58516,539062,989046,293043,297020,26520,2656,25704,374031,043010,493044,8760236,267044,492039,4100185,520019,6400141,57005,5500135,07002,3600156,4900-3,7000159,9300-5,7030172,33006,1430177,280-9,546003,5403,540000000022,23010,863041,790021,226000007,35001,146,000294,00052,000
   Capital Surplus 000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000-11,7660-3,00100000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
205,120
0
173,252
191,770
0
162,372
0
186,740
0
156,257
178,580
143,420
168,000
143,670
171,390
140,100
0
140,350
177,120
134,510
169,310
134,570
174,660
141,660
183,800
141,210
0
185,610
0
195,760
0
169,706
252,567
227,955
0
195,430
0
228,669
278,334
229,565
0
282,327
282,530
247,666
291,730
300,625
304,227
258,024
341,809
-59,789
355,399
-70,625
0
-35,309
-27,585
0
0-27,585-35,3090-70,625355,399-59,789341,809258,024304,227300,625291,730247,666282,530282,3270229,565278,334228,6690195,4300227,955252,567169,7060195,7600185,6100141,210183,800141,660174,660134,570169,310134,510177,120140,3500140,100171,390143,670168,000143,420178,580156,2570186,7400162,3720191,770173,2520205,1200000000000000000000000000



Balance Sheet

Currency in EUR. All numbers in thousands.